AMRN vs AZN Valuation Comparison 2026 — Intrinsic Value Analysis

Quick Summary — AZN scores higher on quality with 10.0/10 vs AMRN's 6.1/10. AMRN trades at $14.47 while AZN trades at $177.45. Both analyzed daily using SEC EDGAR data across 13 institutional models.

AMRN

Drug Manufacturers - General

Amarin Corporation plc

Quality

6.1

out of 10

Value Trap

32

LOW

Price

$14.47

Last close

Models

12/13

Active

VS

AZN

Drug Manufacturers - General

AstraZeneca PLC

Quality

10.0

out of 10

Value Trap

6

SAFE

Price

$177.45

Last close

Models

12/13

Active

AMRN

Earnings Power Value sees +30.4% upside

Limited to 2/13 visible models

AZN

Quality Score 10.0/10 — top tier

Limited to 2/13 visible models

AMRN vs AZN — Fair Value Comparison

AMRN

AZN

Market Price Model 1 Model 2

Model-by-Model Comparison

Model	Type	AMRN Fair Value	AMRN Upside	AZN Fair Value	AZN Upside
Bayesian DCF	Intrinsic	$9.95	-31.2%	$118.84	-33.0%
Earnings Power Value	Intrinsic	$18.35	+30.4%	$72.98	-58.9%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

AMRN vs AZN — Which Stock Is More Undervalued in 2026?

AZN scores higher with a 10.0/10 quality rating vs AMRN's 6.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do AMRN and AZN Valuations Compare?

At $14.47, AMRN trades +31.2% above its Bayesian DCF fair value of $9.95, while AZN at $177.45 trades +33.0% above its estimate of $118.84. AZN shows a wider gap between price and intrinsic value.

Quality of Company: AMRN vs AZN

AMRN earns a Quality of Company score of 6.1/10 compared to AZN's 10.0/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: AMRN vs AZN

AMRN carries a LOW value trap risk (32/100) while AZN shows SAFE risk (6/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Drug Manufacturers - General

Both AMRN and AZN operate in Drug Manufacturers - General, which has 20 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare AMRN vs AZN differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

AMRN

View Full Amarin Corporation plc Analysis →

AZN

View Full AstraZeneca PLC Analysis →